{"id":9835,"date":"2021-12-17T11:53:25","date_gmt":"2021-12-17T11:53:25","guid":{"rendered":"http:\/\/cvx.vc\/?p=9835"},"modified":"2021-12-17T11:53:25","modified_gmt":"2021-12-17T11:53:25","slug":"revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/","title":{"rendered":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit"},"content":{"rendered":"<p><em>*Hvis du er interesseret i at v\u00e6re en del af syndikatinvesteringen eller vil h\u00f8re mere om Perfusion Tech, s\u00e5 kontakt venligst vores Investment Manager S\u00f8ren Lund p\u00e5 <a href=\"mailto:soren@cvx.vc\"><strong>soren@cvx.vc<\/strong><\/a>*<\/em><\/p>\n<p>CVX Ventures g\u00e5r nu sammen med Perfusion Tech om en investeringsrunde p\u00e5 10 mio. kr. CVX Ventures danner et syndikat med en r\u00e6kke MedTech-eksperter i spidsen, som skal st\u00f8tte Perfusion Tech mod det kommercielle gennembrud. Derudover deltager eksisterende investorer ogs\u00e5 i investeringsrunden. Perfusion Tech har fire patenter, og har bl.a. gennem kliniske studier i Danmark, Polen og Holland opn\u00e5et CE-godkendelse.<\/p>\n<p><em>\u201cInvesteringen skal finansiere og kommercialisere vores software. Det er derfor ogs\u00e5 helt afg\u00f8rende, at de nye investorer bringer s\u00e5 meget viden til bordet inden for bl.a. operationel drift, skalering og generel viden inden for vores felt. Derfor har det v\u00e6ret oplagt at g\u00e5 sammen med CVX Ventures om en syndikatinvestering i millionklassen med kompetente CVX-partnere,&#8221;\u00a0<\/em>fort\u00e6ller Mads Aagaard Madsen, CEO og medstifter af Perfusion Tech.<\/p>\n<p>Perfusion Tech blev stiftet i 2016 af iv\u00e6rks\u00e6tterene Mads Aagaard Madsen og Morten Lund med henblik p\u00e5 at \u00f8ge patientsikkerheden under operationer. Perfusion har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer. V\u00e6kstvirksomheden er den f\u00f8rste til at kvantificere blodgennemstr\u00f8mningen i organer og kan tilkobles de systemer og arbejdsgange, der allerede eksisterer p\u00e5 operationsstuer.<\/p>\n<p><em>\u201cPerfusion Tech er f\u00f8rst og fremmest interessant, fordi de l\u00f8ser en stor udfordring i kirugien med deres patenterede l\u00f8sninger, som kan visualisere og kvantificere blodgennemstr\u00f8mningen i organer og v\u00e6v. Nu skal de have kloge penge som skal bidrage til kommercialiseringen af produkterne. Den nuv\u00e6rende ejerkreds foretager endnu en investering ind i runden ved siden af os, og det er et st\u00e6rkt signal om troen p\u00e5 Perfusion Techs potentiale,\u201d<\/em> forklarer S\u00f8ren Lund, Investment Manager i CVX Ventures.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.<\/p>\n","protected":false},"author":25,"featured_media":9836,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit | CVX Ventures<\/title>\n<meta name=\"description\" content=\"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit\" \/>\n<meta property=\"og:description\" content=\"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-17T11:53:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1023\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit\",\"datePublished\":\"2021-12-17T11:53:25+00:00\",\"dateModified\":\"2021-12-17T11:53:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\"},\"wordCount\":326,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\",\"name\":\"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png\",\"datePublished\":\"2021-12-17T11:53:25+00:00\",\"dateModified\":\"2021-12-17T11:53:25+00:00\",\"description\":\"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png\",\"width\":1536,\"height\":1023},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit | CVX Ventures","description":"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/","og_locale":"da_DK","og_type":"article","og_title":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit","og_description":"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","og_url":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2021-12-17T11:53:25+00:00","og_image":[{"width":1536,"height":1023,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png","type":"image\/png"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"2 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit","datePublished":"2021-12-17T11:53:25+00:00","dateModified":"2021-12-17T11:53:25+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/"},"wordCount":326,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/","url":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/","name":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png","datePublished":"2021-12-17T11:53:25+00:00","dateModified":"2021-12-17T11:53:25+00:00","description":"MedTech-virksomheden Perfusion Tech forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/perfusion-tech.png","width":1536,"height":1023},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/revolutionerende-medtech-virksomhed-gar-sammen-med-cvx-ventures-satser-pa-stort-exit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Revolutionerende MedTech-virksomhed g\u00e5r sammen med CVX Ventures: Satser p\u00e5 stort exit"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9835"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=9835"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9835\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/9836"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=9835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=9835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=9835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}